The 2021 Peking University Vascular Forum will be held in Beijing, Capital of China, from October 14 to 16, 2021. Peking University Vascular Forum is one of the largest, most influential and most educational brand conferences in the field of vascular surgery and vascular intervention in China. With the Octoparms® umbrella-shaped vena cava filter and the Swanec® vena cava filter recovery unit, Kossel Medtech a major manufacture of PTCA Balloon Dilatation Catheter and Stent is here to learn from and advance the development of vascular surgery and interventional surgery in China.

Beijing Jishuitan Hospital Professor Tian Xuan shared at the meeting, Octoparms® is the first umbrella retrievable vena cava filter in China, and has been shown to be effective in preventing fatal thrombi of ≥3mm size.

Kossel Medtech Octoparms® vena cava filter is a clinically proven reusable umbrella filter with excellent dynamic stability, long recovery period, simple operation and low complications. It has been approved for sale on 6 August 2021, making it the first of its kind in China. The 2021 Peking University Vascular Forum will be held in Beijing, Capital of China, from October 14 to 16, 2021. Peking University Vascular Forum is one of the largest, most influential and most educational brand conferences in the field of vascular surgery and vascular intervention in China. With the Octoparms® umbrella-shaped vena cava filter and the Swanec® vena cava filter recovery unit, Kossel Medtech a major manufacture of PTCA Balloon Dilatation Catheter and Stent is here to learn from and advance the development of vascular surgery and interventional surgery in China.

Beijing Jishuitan Hospital Professor Tian Xuan shared at the meeting, Octoparms® is the first umbrella retrievable vena cava filter in China, and has been shown to be effective in preventing fatal thrombi of ≥3mm size.

Kossel Medtech Octoparms® vena cava filter is a clinically proven reusable umbrella filter with excellent dynamic stability, long recovery period, simple operation and low complications. It has been approved for sale on 6 August 2021, making it the first of its kind in China.